Mitsubishi Group, Japan

Time frame: 1 January 2023 - 31 December 2023

Profile

The positions in the table below reflect the Mitsubishi Group's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to the corresponding table where Mitsubishi Group is listed.

Position by research output Share

Global Japan
Overall 1395 76
Corporate 45 3

Position by research output Share in subject areas

Global Japan
Biological sciences 997 68
Chemistry 994 60
Earth & environmental sciences 1751
Health sciences 1101 73
Physical sciences 2362 143

Research

Overall research output

Count Share
Overall 25 4.86

Overall Count and Share for 'Mitsubishi Group' based on the 12-month time frame mentioned above.

View all articles

Research outputs by subject area

Subject Count Share
Biological sciences 9 1.72
Chemistry 18 3.40
Earth & environmental sciences 7 0.84
Health sciences 11 1.38
Physical sciences 8 0.89

Note: Articles may be assigned to more than one subject area. Hover over the donut graph to view the Share for each subject.

Share output for the past 5 years

Institution benchmarking

Nature Strategy Reports

Identify research insights to guide research strategy and grow your impact with our Nature Strategy reports.

  1. Actionable insights into research performance.

  2. Detailed analysis of strengths and weaknesses.

  3. Covers all major disciplines and regions of the world.

Nature Navigator

Data-driven insights for informed research strategy decisions with AI summarisation technology.

  1. Track trends, summarise articles effortlessly.

  2. Spark serendipitous discoveries.

  3. Uncover collaboration opportunities.

Collaboration

International vs domestic collaboration by Share

Type Percentage
International (57 institutions) 42.5%
Domestic (93 institutions) 57.5%

Note: Hover over the graph to view the percentage of collaboration.

Top 5 domestic collaborators with Mitsubishi Group by Share

Collaborating institutions

Share

Top 5 international collaborators with Mitsubishi Group by Share

Collaborating institutions

Share

  • Advertisement

Latest supplement

Nature Index 2024 Health Sciences

More money is being spent on medical R&D than ever before, but with few new drugs to show for it. The race is on to find technological solutions that will speed up drug development and deliver better clinical outcomes. Nature Index Health Sciences 2024 highlights the people and projects that are bringing fresh perspectives to some of the most complex challenges in medicine and provides an in-depth look at how one country – the United States – is dominating the field.

Nature Index 2024 Health Sciences